CompBrief BY VELARION

Companies Lumexa Imaging Holdings, Inc.

Lumexa Imaging (LMRI): executive pay, fiscal 2025

Free brief. Every figure links to the company’s own filing.

Email me Lumexa Imaging Holdings, Inc.’s executive pay brief as a PDF

It arrives in about 2 minutes, with every figure cited to its filing.

After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.

CEO total pay$19,468,208CEO Caitlin Zulla · source

CEO pay, last three years

  • $19,468,208FY2025

CEO total pay was $19,468,208 in fiscal 2025; the brief holds no earlier figure for this CEO.

FY2025: salary $750,000 · bonus $3,500,000 · stock awards $5,430,782 · option awards $9,022,219

Order LMRI

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Executives and directors

Full detail

Every table from the filing. Open any section.

Summary compensation table
Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Caitlin Zulla$750,000$3,500,000$5,430,782$9,022,219$750,000$0$0$19,468,208
Chief Executive Officer
Tony Martin590,000—2,427,8374,210,361590,000——7,838,736
Chief Financial Officer
Julie Szeker450,0001,750,0002,095,813663,4660—15,5054,995,322
Former Chief Legal Officer and Corporate Secretary

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Caitlin Zulla$19,468,208———
Tony Martin7,838,736———
Julie Szeker4,995,322———

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

Our executive compensation program is intended to align executive compensation with our business objectives and to enable us to attract, retain and reward executive officers who contribute to our long-term success.

CEO STI target (% of salary)—
CEO LTI target (% of salary)—
Independent consultantF.W. Cook
Clawback policytrue
Anti-hedgingtrue
Anti-pledging—
Equity grants and outstanding awards

No plan-based awards are on file for this fiscal year.

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Julie SzekerPSU11,876—$219,706
Julie SzekerOption13,33318.5—
Tony MartinRSU27,027—500,000
Tony MartinPSU27,027—500,000
Julie SzekerOption31,94418.5—
Julie SzekerOption63,88718.5—
Caitlin ZullaRSU64,864—1,199,984
Caitlin ZullaPSU64,864—1,199,984
Julie SzekerRSU81,081—1,500,000
Tony MartinOption388,88818.5—
Caitlin ZullaOption833,33318.5—
Director compensation
DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Lee CooperNot independent · Board Chair$5,150,000$0———$5,150,000
Molly JosephIndependent · Lead Independent Director · Audit · Nominating and Corporate Governance (Chair)150,000500,000———650,000
Brett BrodnaxIndependent · Compensation (Chair) · Nominating and Corporate Governance · Patient Safety and Quality of Care91,250500,000———591,250
Glenn EisenbergIndependent · Audit (Chair) · Compensation95,00088,000———183,000
Bridget KarlinIndependent · Audit · Technology (Chair)95,00088,000———183,000
Matthew Lungren, MDIndependent · Technology · Patient Safety and Quality of Care (Chair)29,16788,000———117,167
Ann PumpianIndependent80,0000———80,000
Christian RiceNot independent00———0
Robert Mittl, MDNot independent · Technology · Patient Safety and Quality of Care00———0
Sean Bryant, MDNot independent00———0
Rasu ShresthaNot independent00———0
David JeckIndependent00———0
Brian ReganIndependent · Compensation · Nominating and Corporate Governance00———0
Jon Fromke, MDNot independent00———0
Caitlin ZullaEmployee director—————0

Board fee structure and ownership guideline

Annual cash retainer$85,000
Annual equity retainer$175,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)25,000 / 20,000 / 15,000
Stock ownership guideline—

Total cost of the board

ComponentFY2025
Cash retainers and fees$5,690,417
Equity awards (grant-date value)$1,264,000
All other compensation$0
Total cost of the board$6,954,417

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names Lumexa Imaging as a peer

Companies that benchmark against LMRI

No companies currently name LMRI as a compensation peer in their most recent disclosure.

This is the complete answer, not a partial one — the list is never padded.

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Lumexa Imaging Holdings, Inc.2025Caitlin Zulla$750,000$5,430,782$9,022,219$750,000$19,468,208

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Say-on-pay history and pay ratio
Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-10—————

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting yearMeeting dateApproval — company’s computation
20262026-06-10—a

a. Voting standard not stated in the filing.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

Insider trades since the proxy

No insider equity transactions reported since the proxy statement.

Sources (21 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

  • Section 01, Caitlin Zulla. DEF 14A, filed 2026-04-28. Section “Executive Compensation”. As printed: 19,468,208. View filing ↗
  • Section 01, Tony Martin. DEF 14A, filed 2026-04-28. Section “Executive Compensation”. As printed: 7,838,736. View filing ↗
  • Section 01, Julie Szeker. DEF 14A, filed 2026-04-28. Section “Executive Compensation”. As printed: 4,995,322. View filing ↗
  • Section 08, Lee Cooper. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 5,150,000. View filing ↗
  • Section 08, Molly Joseph. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 650,000. View filing ↗
  • Section 08, Brett Brodnax. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 591,250. View filing ↗
  • Section 08, Glenn Eisenberg. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 183,000. View filing ↗
  • Section 08, Bridget Karlin. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 183,000. View filing ↗
  • Section 08, Matthew Lungren, MD. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 117,167. View filing ↗
  • Section 08, Ann Pumpian. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 80,000. View filing ↗
  • Section 08, Christian Rice. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 08, Robert Mittl, MD. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 08, Sean Bryant, MD. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 08, Rasu Shrestha. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 08, David Jeck. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 08, Brian Regan. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 08, Jon Fromke, MD. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 08, Caitlin Zulla. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 06, 2026 vote. Form 8-K, filed 2026-06-12. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
  • Section 09b board cost (computed). Computed. Cash 5,690,417 + equity 1,264,000 + all other 0 = 6,954,417, summed across the director compensation table rows.
  • Lumexa Imaging Holdings, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Lumexa Imaging Holdings, Inc.'s own proxy. As printed: 19,468,208. View filing ↗
Get the full report — $1,500